Product Description: Fletikumab (NNC0109-0012) is a monoclonal antibody targeting to IL-20. Fletikumab can be used for inflammation research, such as rheumatoid arthritis[1].
Applications: COVID-19-immunoregulation
Formula: N/A
References: [1]Kragstrup TW, et al. The IL-20 Cytokine Family in Rheumatoid Arthritis and Spondyloarthritis. Front Immunol. 2018 Sep 25;9:2226. /[2]Tian-Yu Lin, et al. IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target. Int. J. Mol. Sci. 2020, 21(3), 1009.
CAS Number: 1357158-22-5
Molecular Weight: N/A
Compound Purity: 99.24
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Interleukin Related